333 related articles for article (PubMed ID: 24451586)
1. Validation of N-myristoyltransferase as an antimalarial drug target using an integrated chemical biology approach.
Wright MH; Clough B; Rackham MD; Rangachari K; Brannigan JA; Grainger M; Moss DK; Bottrill AR; Heal WP; Broncel M; Serwa RA; Brady D; Mann DJ; Leatherbarrow RJ; Tewari R; Wilkinson AJ; Holder AA; Tate EW
Nat Chem; 2014 Feb; 6(2):112-21. PubMed ID: 24451586
[TBL] [Abstract][Full Text] [Related]
2. Homology modeling and molecular dynamics simulation of N-myristoyltransferase from Plasmodium falciparum: an insight into novel antimalarial drug design.
Paul P; Chowdhury A; Das Talukdar A; Choudhury MD
J Mol Model; 2015 Mar; 21(3):37. PubMed ID: 25663521
[TBL] [Abstract][Full Text] [Related]
3. Identification of Selective Inhibitors of
Harupa A; De Las Heras L; Colmenarejo G; Lyons-Abbott S; Reers A; Caballero Hernandez I; Chung CW; Charter D; Myler PJ; Fernández-Menéndez RM; Calderón F; Palomo S; Rodríguez B; Berlanga M; Herreros-Avilés E; Staker BL; Fernández Álvaro E; Kaushansky A
J Med Chem; 2020 Jan; 63(2):591-600. PubMed ID: 31850752
[TBL] [Abstract][Full Text] [Related]
4. Structure-Guided Identification of Resistance Breaking Antimalarial N‑Myristoyltransferase Inhibitors.
Schlott AC; Mayclin S; Reers AR; Coburn-Flynn O; Bell AS; Green J; Knuepfer E; Charter D; Bonnert R; Campo B; Burrows J; Lyons-Abbott S; Staker BL; Chung CW; Myler PJ; Fidock DA; Tate EW; Holder AA
Cell Chem Biol; 2019 Jul; 26(7):991-1000.e7. PubMed ID: 31080074
[TBL] [Abstract][Full Text] [Related]
5. N-Myristoylation as a Drug Target in Malaria: Exploring the Role of N-Myristoyltransferase Substrates in the Inhibitor Mode of Action.
Schlott AC; Holder AA; Tate EW
ACS Infect Dis; 2018 Apr; 4(4):449-457. PubMed ID: 29363940
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel and ligand-efficient inhibitors of Plasmodium falciparum and Plasmodium vivax N-myristoyltransferase.
Rackham MD; Brannigan JA; Moss DK; Yu Z; Wilkinson AJ; Holder AA; Tate EW; Leatherbarrow RJ
J Med Chem; 2013 Jan; 56(1):371-5. PubMed ID: 23170970
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of inhibitors of Plasmodium falciparum N-myristoyltransferase, a promising target for antimalarial drug discovery.
Yu Z; Brannigan JA; Moss DK; Brzozowski AM; Wilkinson AJ; Holder AA; Tate EW; Leatherbarrow RJ
J Med Chem; 2012 Oct; 55(20):8879-90. PubMed ID: 23035716
[TBL] [Abstract][Full Text] [Related]
8. In Silico screening on the three-dimensional model of the Plasmodium vivax SUB1 protease leads to the validation of a novel anti-parasite compound.
Bouillon A; Giganti D; Benedet C; Gorgette O; Pêtres S; Crublet E; Girard-Blanc C; Witkowski B; Ménard D; Nilges M; Mercereau-Puijalon O; Stoven V; Barale JC
J Biol Chem; 2013 Jun; 288(25):18561-73. PubMed ID: 23653352
[TBL] [Abstract][Full Text] [Related]
9. QSAR, docking and ADMET studies of artemisinin derivatives for antimalarial activity targeting plasmepsin II, a hemoglobin-degrading enzyme from P. falciparum.
Qidwai T; Yadav DK; Khan F; Dhawan S; Bhakuni RS
Curr Pharm Des; 2012; 18(37):6133-54. PubMed ID: 22670592
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization and in vitro evaluation of novel enantiomerically-pure sulphonamide antimalarials.
Anusha S; Sinha A; Babu Rajeev CP; Chu TT; Mathai J; Ximei H; Fuchs JE; Shivananju N; Bender A; Preiser PR; Rangappa KS; Basappa ; Chandramohanadas R
Org Biomol Chem; 2015 Nov; 13(43):10681-90. PubMed ID: 26347024
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of high affinity inhibitors of Plasmodium falciparum and Plasmodium vivax N-myristoyltransferases directed by ligand efficiency dependent lipophilicity (LELP).
Rackham MD; Brannigan JA; Rangachari K; Meister S; Wilkinson AJ; Holder AA; Leatherbarrow RJ; Tate EW
J Med Chem; 2014 Mar; 57(6):2773-88. PubMed ID: 24641010
[TBL] [Abstract][Full Text] [Related]
12. Plasmodium falciparum dihydroorotate dehydrogenase: a drug target against malaria.
Hoelz LV; Calil FA; Nonato MC; Pinheiro LC; Boechat N
Future Med Chem; 2018 Aug; 10(15):1853-1874. PubMed ID: 30019917
[TBL] [Abstract][Full Text] [Related]
13. Molecules incorporating a benzothiazole core scaffold inhibit the N-myristoyltransferase of Plasmodium falciparum.
Bowyer PW; Gunaratne RS; Grainger M; Withers-Martinez C; Wickramsinghe SR; Tate EW; Leatherbarrow RJ; Brown KA; Holder AA; Smith DF
Biochem J; 2007 Dec; 408(2):173-80. PubMed ID: 17714074
[TBL] [Abstract][Full Text] [Related]
14. QSAR Study of
Santos-Garcia L; de Mecenas Filho MA; Musilek K; Kuca K; Ramalho TC; da Cunha EFF
Molecules; 2018 Sep; 23(9):. PubMed ID: 30217086
[TBL] [Abstract][Full Text] [Related]
15. In silico identification of promiscuous scaffolds as potential inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase for treatment of Falciparum malaria.
Wadood A; Ghufran M; Hassan SF; Khan H; Azam SS; Rashid U
Pharm Biol; 2017 Dec; 55(1):19-32. PubMed ID: 27650666
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel N-branched acyclic nucleoside phosphonates as potent and selective inhibitors of human, Plasmodium falciparum and Plasmodium vivax 6-oxopurine phosphoribosyltransferases.
Hocková D; Keough DT; Janeba Z; Wang TH; de Jersey J; Guddat LW
J Med Chem; 2012 Jul; 55(13):6209-23. PubMed ID: 22725979
[TBL] [Abstract][Full Text] [Related]
17. KBE009: An antimalarial bestatin-like inhibitor of the Plasmodium falciparum M1 aminopeptidase discovered in an Ugi multicomponent reaction-derived peptidomimetic library.
González-Bacerio J; Maluf SEC; Méndez Y; Pascual I; Florent I; Melo PMS; Budu A; Ferreira JC; Moreno E; Carmona AK; Rivera DG; Alonso Del Rivero M; Gazarini ML
Bioorg Med Chem; 2017 Sep; 25(17):4628-4636. PubMed ID: 28728898
[TBL] [Abstract][Full Text] [Related]
18. N-Myristoyltransferase as a potential drug target in malaria and leishmaniasis.
Tate EW; Bell AS; Rackham MD; Wright MH
Parasitology; 2014 Jan; 141(1):37-49. PubMed ID: 23611109
[TBL] [Abstract][Full Text] [Related]
19. Identification of new oxospiro chromane quinoline-carboxylate antimalarials that arrest parasite growth at ring stage.
Jameel E; Madhav H; Agrawal P; Raza MK; Ahmedi S; Rahman A; Shahid N; Shaheen K; Gajra CH; Khan A; Malik MZ; Imam MA; Kalamuddin M; Kumar J; Gupta D; Nayeem SM; Manzoor N; Mohammad A; Malhotra P; Hoda N
J Biomol Struct Dyn; 2023; 41(24):15485-15506. PubMed ID: 36970842
[TBL] [Abstract][Full Text] [Related]
20. Peptidomimetic inhibitors of N-myristoyltransferase from human malaria and leishmaniasis parasites.
Olaleye TO; Brannigan JA; Roberts SM; Leatherbarrow RJ; Wilkinson AJ; Tate EW
Org Biomol Chem; 2014 Nov; 12(41):8132-7. PubMed ID: 25230674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
